Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 75,621 |
|
|||||
| News | - | ||||||
| Day High | 1.07 | Low High |
|||||
| Day Low | 0.9926 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Xilio Therapeutics Inc | XLO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.06 | -5.56% | 1.02 | 09:19:46 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.04 | 0.9926 | 1.07 | 1.08 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 97 | 75,621 | US$ 1.05 | US$ 79,412 | - | 0.49 - 3.2499 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:09:15 | 100 | US$ 1.02 | USD |
Xilio Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 29.19M | 27.54M | - | 0 | -76.4M | -2.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Xilio Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XLO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.9108 | 1.10 | 0.86 | 1.01 | 186,115 | 0.1092 | 11.99% |
| 1 Month | 1.29 | 1.32 | 0.8366 | 1.09 | 200,510 | -0.27 | -20.93% |
| 3 Months | 0.68 | 1.93 | 0.58 | 1.24 | 1,295,934 | 0.34 | 50.00% |
| 6 Months | 0.9905 | 1.93 | 0.49 | 1.15 | 720,554 | 0.0295 | 2.98% |
| 1 Year | 2.98 | 3.2499 | 0.49 | 1.17 | 368,050 | -1.96 | -65.77% |
| 3 Years | 15.00 | 27.95 | 0.49 | 2.66 | 188,043 | -13.98 | -93.20% |
| 5 Years | 15.00 | 27.95 | 0.49 | 2.66 | 188,043 | -13.98 | -93.20% |
Xilio Therapeutics Description
| Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index. |
